Sanlar Theradiagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 8 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue Growth %
- Profit Growth 14.74%
- Ebitda 14.76%
- Net Worth -51.08%
- Total Assets %
About Sanlar Theradiagnostics
Sanlar Theradiagnostics Private Limited (STPL) is a Private Limited Indian Non-Government Company incorporated in India on 25 July 2016 (Eight years and six months 20 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anshuman Sugla and Sangeeta Sugla serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U36999MH2016PTC284044
-
Company No.
284044
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
25 Jul 2016
-
Date of AGM
25 Sep 2019
-
Date of Balance Sheet
31 Mar 2019
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sanlar Theradiagnostics?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anshuman Sugla
|
Director | 25-Jul-2016 | Current |
|
Sangeeta Sugla
|
Director | 25-Jul-2016 | Current |
Financial Performance of Sanlar Theradiagnostics.
Sanlar Theradiagnostics Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 14.74% increase in profit. The company's net worth observed a substantial decline by a decrease of 51.08%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sanlar Theradiagnostics?
In 2019, Sanlar Theradiagnostics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Sanlar Imex Services Private LimitedAnshuman Sugla and Sangeeta Sugla are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sanlar Theradiagnostics?
Unlock and access historical data on people associated with Sanlar Theradiagnostics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sanlar Theradiagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sanlar Theradiagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.